Michael Potter

Dr. Michael Potter


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2017 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MPMichael Potter
Michael Potter
SBStephen C Brienesse
Stephen C Brienesse
MWMarjorie M Walker
Marjorie M Walker
ABAndrew Boyle
Andrew Boyle
NTNicholas J Talley
Nicholas J Talley

28 September 2019 in Gut
Verified
Journal Article
Closed access
PDF file
Nicholas TalleyNicholas Talley
Nicholas Talley
GHGerald J Holtmann
Gerald J Holtmann
MJMichael Jones
Michael Jones
NKNatasha A Koloski
Natasha A Koloski
MWMarjorie M Walker
Marjorie M Walker
SKSimon Keely
Simon Keely

30 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MPMichael Potter
Michael Potter
Kerith DuncansonKerith Duncanson
Kerith Duncanson
MJMichael P. Jones
Michael P. Jones
MWMarjorie Walker
Marjorie Walker
SKSimon Keely
Simon Keely
Nicholas TalleyNicholas Talley
Nicholas Talley
Introduction: Functional dyspepsia (FD), characterised by symptoms of epigastric pain or early satiety and post prandial distress, has been associated with duodenal eosinophilia, raising the possibility that it is driven by an environmental allergen. Non-coeliac gluten or wheat sensitivity (NCG/WS) has also been associated with both dyspeptic symptoms and duodenal eosinophilia, suggesting an overlap between these two conditions. The aim of this study was to evaluate the role of wheat (specifically gluten and fructans) in symptom reduction in participants with FD in a pilot randomized double-blind, placebo controlled, dietary crossover trial. Methods: Patients with Rome III criteria FD were recruited from a single tertiary centre in Newcastle, Australia. All were individually counselled on a diet low in both gluten and fermentable oligo-, di-, mono-saccharides, and polyols (FODMAPs) by a clinical dietitian, which was followed for four weeks (elimination diet phase). Those who had a ≥30% response to the run-in diet, as measured by the Nepean Dyspepsia Index, were then re-challenged with ‘muesli’ bars containing either gluten, fructan, or placebo in randomised order. Those with symptoms which significantly reduced during the elimination diet, but reliably reappeared (a mean change in overall dyspeptic symptoms of ≥30%) with gluten or fructan re-challenge were deemed to have wheat induced FD. Results: Eleven participants were enrolled in the study (75% female, mean age 43 years). Of the initial cohort, nine participants completed the elimination diet phase of whom four qualified for the rechallenge phase. The gluten-free, low FODMAP diet led to an overall (albeit non-significant) improvement in symptoms of functional dyspepsia in the diet elimination phase (mean NDI symptom score 71.2 vs. 47.1, p = 0.087). A specific food trigger could not be reliably demonstrated. Conclusions: Although a gluten-free, low-FODMAP diet led to a modest overall reduction in symptoms in this cohort of FD patients, a specific trigger could not be identified. The modified Salerno criteria for NCG/WS identification trialled in this dietary rechallenge protocol was fit-for-purpose. However, larger trials are required to determine whether particular components of wheat induce symptoms in functional dyspepsia.

3 April 2019 in Gut
Verified
Journal Article
Closed access
PDF file
MPMichael Potter
Michael Potter
TGThomas M Goodsall
Thomas M Goodsall
MWMarjorie M Walker
Marjorie M Walker
NTNicholas J Talley
Nicholas J Talley
We read with interest the paper by Camilleri and Boeckxstaens1 which summarises the role of mast cells and their mediators in the pathogenesis of functional gastrointestinal disorders, and describes the particular role of histamine action on H1 receptors in submucosal neurons in rectal biopsies, as well as the clinical response to H1 blockade observed in some patients with the IBS. Mast cells are implicated in both IBS and to a lesser extent in functional dyspepsia.2 These cells release, among other mediators, histamine, which acts on histamine receptors on submucosal neurons, as well as on epithelial cells causing secretion of chloride and bicarbonate.2 Histamine-2 receptor blockade …

1 June 2019 in Best Practice & Research Clinical Gastroenterology
Verified
Journal Article
Closed access
MWMarjorie Walker
Marjorie Walker
MPMichael Potter
Michael Potter
Nicholas TalleyNicholas Talley
Nicholas Talley

29 June 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
MPMichael Potter
Michael Potter
MWMarjorie Walker
Marjorie Walker
SHStephen Hancock
Stephen Hancock
EHElizabeth Holliday
Elizabeth Holliday
GBGregory Brogan
Gregory Brogan
JAJohn Attia
John Attia
Previously thought to be mainly a disorder of childhood and early adult life, coeliac disease (CeD) is increasingly diagnosed in older adults. This may be important given the association between CeD and osteoporosis. The primary aim of this study was to determine the seroprevalence of undiagnosed CeD (‘at-risk serology’) in an older Australian community and relate this to a diagnosis of osteoporosis and fractures during a follow-up period of 12 years. We included participants from the Hunter Community Study (2004–2007) aged 55–85, who had anti-tissue transglutaminase (tTG) titres, human leukocyte antigen (HLA) genotypes, and bone mineral density measurements at baseline. Follow-up data included subsequent diagnosis of CeD and fractures using hospital information. ‘At-risk’ serology was defined as both tTG and HLA positivity. Complete results were obtained from 2122 patients. The prevalence of ‘at-risk’ serology was 5%. At baseline, 3.4% fulfilled criteria for a diagnosis of osteoporosis. During a mean of 9.7 years of follow-up, 7.4% of the cohort suffered at least one fracture and 0.7% were subsequently diagnosed with CeD. At-risk serology was significantly associated with osteoporosis in a multivariate model (odds ratio 2.83, 95% confidence interval 1.29–6.22); there was insufficient power to look at the outcome of fractures. The results of this study demonstrate that at-risk CeD serology was significantly associated with concurrent osteoporosis but not future fractures. Most individuals with a serological diagnosis of CeD were not diagnosed with CeD during the follow-up period according to medical records. Coeliac disease likely remains under-diagnosed.